Real-World Effectiveness in Biologics for CRSwNP

button-block-bgcheckcheckmarkCME badgeCMEcmebadgeCMEdownloadeuforeatveyefacebookfaqglobeicon_1icon_2icon_3Middel 1iconmonstr-facebook-1iconmonstr-info-8iconmonstr-linkedin-1iconmonstr-twitter-1iconmonstr-video-13iconmonstr-youtube-1infographic-blueinfographic-blueinfographic-bulbinfographic-darkblueinforgraphic-yellowinstagramlinkedinpdfpinterestquestionmarksmartphonespotifytweetstwitteryoutube

Join the Masterclass at the time that suits you best!

We’re offering two sessions on November 20th, 2025:

  • 9 AM CET
  • 5 PM CET

Upon registration, you will be eligible to access the recorded session, which will be available on our Academy platform at a later stage.

Masterclass

Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging condition, and biologic therapies are transforming patient outcomes. This live masterclass will provide an up-to-date overview of the latest real-world evidence (RWE) data on three key biologics in CRSwNP as of 2025.

Click here to access the programme of this masterclass.

Participants will:

  • Gain insights into the current efficacy and safety data from real-world practice.
  • Learn how to critically interpret the strengths and limitations of RWE compared to clinical trial data.
  • Explore practical guidance on patient and treatment selection to optimise outcomes in CRSwNP and nasal polyp syndrome.

Designed for ENT specialists, allergists, pulmonologists, and all clinicians managing CRSwNP, this session will combine evidence-based updates with expert perspectives to support confident, individualised treatment decisions.

👉 This masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s).

Q&A

Our Healthcare Professionals are always keen to help you in answering any questions you might have. To assist you efficiently, please complete the form below by specifying the questions you would like our experts to address.

Accreditation Statement

The Real-World Effectiveness in Biologics for CRSwNP, Virtual, Belgium 20/11/2025 - 20/11/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

button-block-bgcheckcheckmarkCME badgeCMEcmebadgeCMEdownloadeuforeatveyefacebookfaqglobeicon_1icon_2icon_3Middel 1iconmonstr-facebook-1iconmonstr-info-8iconmonstr-linkedin-1iconmonstr-twitter-1iconmonstr-video-13iconmonstr-youtube-1infographic-blueinfographic-blueinfographic-bulbinfographic-darkblueinforgraphic-yellowinstagramlinkedinpdfpinterestquestionmarksmartphonespotifytweetstwitteryoutube